Tscan Therapeutics Inc (NASDAQ:TCRX) has a beta value of 0.97 and has seen 1.18 million shares traded in the last trading session. The company, currently valued at $99.03M, closed the last trade at $1.75 per share which meant it gained $0.29 on the day or 19.86% during that session. The TCRX stock price is -430.86% off its 52-week high price of $9.29 and 41.71% above the 52-week low of $1.02.
The consensus among analysts is that Tscan Therapeutics Inc (TCRX) is Buy stock at the moment, with a recommendation rating of 1.12. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight.
Tscan Therapeutics Inc (NASDAQ:TCRX) trade information
Over the past 30 days, the shares of Tscan Therapeutics Inc (NASDAQ:TCRX) have changed 9.38%.
Wall Street analysts have a consensus price target for the stock at $3, which means that the shares’ value could jump 41.67% from current levels. The projected low price target is $3.0 while the price target rests at a high of $3.0. In that case, then, we find that the current price level is -71.43% off the targeted high while a plunge would see the stock gain -71.43% from current levels.
Tscan Therapeutics Inc (TCRX) estimates and forecasts
The company’s shares have lost -63.31% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -14.41% over the past 5 years. Earnings growth for 2025 is a modest -9.10% while over the next 5 years, the company’s earnings are expected to increase by 9.18%.
TCRX Dividends
Tscan Therapeutics Inc is expected to release its next earnings report in July this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Tscan Therapeutics Inc (NASDAQ:TCRX)’s Major holders
The top two institutional holders are LYNX1 CAPITAL MANAGEMENT LP with over 5.22 million shares worth more than $30.56 million. As of 2024-06-30, LYNX1 CAPITAL MANAGEMENT LP held 4.6062% of shares outstanding.
The other major institutional holder is ECOR1 CAPITAL, LLC, with the holding of over 5.0 million shares as of 2024-06-30. The firm’s total holdings are worth over $29.25 million and represent 4.4082% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and Simplify Exchange Traded Funds-Simplify Propel Opportunities ETF . As of Mar 31, 2025 , the former fund manager holds about 2.62% shares in the company for having 1.37 shares of worth $2.4 million while later fund manager owns 1.05 shares of worth $1.83 million as of Mar 31, 2025 , which makes it owner of about 2.00% of company’s outstanding stock.
